Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats

Eur Neuropsychopharmacol. 2008 Jan;18(1):74-7. doi: 10.1016/j.euroneuro.2007.05.006. Epub 2007 Aug 1.

Abstract

An endogenous natriuretic and vasoconstrictor Na/K-ATPase inhibitor, marinobufagenin (MBG), is implicated in NaCl-induced hypertension and in ethanol addiction. In rats, MBG suppresses voluntary alcohol intake, while immunization against MBG induces alcohol-seeking behavior. Since alcohol withdrawal is associated with elevation of blood pressure (BP) and renal sodium retention, we hypothesized that MBG mediates pressor response to ethanol withdrawal. In male Sprague-Dawley rats, forced ethanol intake (20% v/v, 2.8+/-0.2 g/day for 7 days) did not affect BP and MBG excretion. Ethanol withdrawal was associated with a 21 mm Hg increase in BP, a 10% decrease in hematocrit, and a three-fold increase in renal MBG excretion. In vivo administration of anti-MBG antibody to rats prevented withdrawal-induced BP elevation. Therefore, MBG mediates pressor response to ethanol withdrawal, and may link mechanisms of ethanol dependence and hypertension.

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Bufanolides / therapeutic use*
  • Bufanolides / urine
  • Central Nervous System Depressants*
  • Ethanol*
  • Hematocrit
  • Male
  • Ouabain / urine
  • Rats
  • Rats, Sprague-Dawley
  • Sodium / urine
  • Substance Withdrawal Syndrome / drug therapy*
  • Substance Withdrawal Syndrome / physiopathology*
  • Vasoconstrictor Agents / therapeutic use*
  • Vasoconstrictor Agents / urine

Substances

  • Bufanolides
  • Central Nervous System Depressants
  • Vasoconstrictor Agents
  • Ethanol
  • marinobufagenin
  • Ouabain
  • Sodium